The life science regulatory landscape in Europe is evolving quickly and irrevocably. These changes are anticipated to strengthen the regulatory platform and to slowly drift apart from the siloed approach practiced by device manufacturers and related organizations in the EU. In this webinar, you will have an opportunity to question and develop a comprehensive, and advanced understanding of the potential strategic solutions for EU MDR compliance, regardless of where you are in the transition process. Additionally, you will also learn how to proactively take advantage of the extension for both MDD renewal and MDR implementation to effectively manage every facet of the regulatory change.
Celegence’s leadership team, with a combined experience of over 25-years within the pharma industry and 15 years in Regulatory Affairs will sponsor an online webcast in conjunction with RAPS showing you how to take advantage of the EU MDR delay.
What: Webinar in conjunction with RAPS showing you how to take advantage of the EU MDR delay.
When: July 22nd 2020, 11.00am – 12.30pm EST
Where: Online Event
How: Register online now
Why: You will learn what the EU-MDR extension means for your organization, and how the extra time should be leveraged for both new and legacy devices.
You can learn more about the webinar here.